This report provides exclusive insights into the COVID-19 impact on the In-Vitro Fertilization Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the In-Vitro Fertilization Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of In-Vitro Fertilization Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
A recent report published by Infinium Global Research on In-Vitro fertilization market provides in-depth analysis of segments and sub-segments in global as well as regional In-Vitro fertilization market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional in-Vitro fertilization market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global In-Vitro fertilization market. According to the report, the global In-Vitro fertilization market is projected to grow at a CAGR of 6% over the forecast period of 2018-2024.
In-Vitro fertilization is the process of artificial fertilization used to treat infertility or genetic problems worldwide. In this process egg and sperm are combined manually in a laboratory and then embryo(s) is transferred to the uterus with the objective of establishing a successful pregnancy. This is the most effective assisted reproductive technology that helps couples or single parents across the world. This process is used for infertility treatment and gestational surrogacy in which a fertilized egg is inserted into a surrogate's uterus and the child is genetically unrelated to the surrogate. Improving health care infrastructure and favorable healthcare cost are driving the growth of the market. Further, the market growth is attributed by the reduced conceiving rates mainly in women aged 40 years or more, ovulation disorder, damaged or blocked the fallopian tube, premature ovarian failure, impaired sperm production or function, and unexplained infertility are the factors, further leading to the market growth.
A growing number of men and women who are focusing on their career are freezing their eggs/sperms to have the child some years later. Further government funding to encourage egg/sperm freezing and provide with a chance of multiple pregnancies, technological advancements that allow the analysis of the genetic disorder, and various industrial revolutions are expected to boom the market growth. Additionally, delay in pregnancies in many cases leads to pregnancy-associated complications and increase the chance of infertility thus, results in the adoption of In-Vitro fertilization which boost the market growth. However, on the flip side high cost involved in In-Vitro fertilization may hamper the growth of this market.
Among the geographies, the Asia-Pacific region accounts for the largest market share of the In-Vitro fertilization market followed by Europe. In Asia-Pacific region factors such as an increase in the median age of the first-time motherhood, rising prevalence of PCOS, growth in fertility tourism, increasing infertility rates and government initiatives are driving the growth of In-Vitro fertilization market in this region. Further, in the Europe region, growing demand for fertility treatment is boosting the growth in this market.
The report on global In-Vitro fertilization market covers segments such as instrument, technology, and end-user. On the basis of the instrument, the global In-Vitro fertilization market is categorized into the cabinet, micromanipulator, incubators, sperm aspiration pump and ovum aspiration pump. On the basis of technology, the global In-Vitro fertilization market is categorized into preimplantation genetic diagnosis and intra-cytoplasmic sperm injection. On the basis of end-user, the global In-Vitro fertilization market is categorized into hospitals, fertility clinics, and cryobanks.
The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region.
The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-Pacific region offers substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global In-Vitro fertilization market such as Cook Medical Inc., Hamilton Thorne, Inc., Laboratoire CCD, Nidacon International AB, Thermo Fisher Scientific Inc., Coopersurgical Inc., Irvine Scientific, Merck KGaA, Nikon Corporation, and Vitrolife AB.
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global In-Vitro fertilization market. Moreover, IGR-Growth Matrix analysis given in the report brings insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of In-Vitro fertilization market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the In-Vitro fertilization market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the In-Vitro fertilization market to understand the present and future trends in this market and formulate their strategies accordingly.